QP4PHARMA@Solutions
ActiveSummary
QP4PHARMA@Solutions has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €246k and a net result of €51k. Equity is growing by ~38.2% per year across the filed fiscal years. Its solvency ranks better than 79% of 31694 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
92
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability90▼-10
Solvency100▲+3
Growth52▼-26
Track record94
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €22k at 30 days acceptable
Liquidity ample (current ratio 5.46 against 3.18 in 2024; short-term debt: 18% and cash: 79.7% of total assets), and 18% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 70
Relative position
BE, all sectors
reference
Sector 70
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
82%
Return on assets
17.1%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-03-2026, 126 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
126 d early
2024
on the day
2023
1 d early
2022
5 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€246k=
2024 · €246k
2022: €61k
2023: €151k
2024: €246k
2022 → 2025
Total assets
€300k▼ 12.1%
2024 · €341k
2022: €99k
2023: €205k
2024: €341k
2022 → 2025
Net result
€51k▼ 46.3%
2024 · €95k
2022: €56k
2023: €90k
2024: €95k
2022 → 2025
Working capital
€241k▲ 15.8%
2024 · €208k
2022: €53k
2023: €100k
2024: €208k
2022 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line2022202320242025Trend
Equity€61k-€151k▲ 148%€246k▲ 63.3%€246k=
Operating result€82k-€133k▲ 61.5%€133k▼ 0.1%€68k▼ 48.4%
Net result€56k-€90k▲ 61.3%€95k▲ 6.0%€51k▼ 46.3%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 48% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €300k
Fixed assets
€5k ▼ 86.8%
Current assets
€295k ▼ 2.8%
Equity and liabilities €300k
Equity
€246k =
Debt
€54k ▼ 43.3%
Debt's share of the balance-sheet total falls from 27.9% to 18.0%. Debt is lower.
Key figures and ratios
EBITDA
€70k▼
2024 · €146k
Cash flow
€53k▼
2024 · €109k
Current ratio
5.46▲
2024 · 3.18
Debt to equity
0.22▼
2024 · 0.39
ROE
20.8%▼
2024 · 38.8%
ROA
17.1%▼
2024 · 27.9%
Interest coverage
240.17▼
2024 · 584.96
Debt ≤ 1 year
€54k▼
2024 · €95k
Income taxes
€19k▼
2024 · €41k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 44 lines
Balance sheet
Code20242025
Assets
Total assets20/58€341k€300k▼
Formation expenses20€0€0=
Fixed assets21/28€38k€5k▼
Intangible fixed assets21€5k€5k▼
Tangible fixed assets22/27€33k€510▼
Furniture and vehicles24€33k€510▼
Current assets29/58€304k€295k▼
Amounts receivable within one year40/41€68k€56k▼
Trade receivables40€37k€11k▼
Other amounts receivable41€31k€45k▲
Current investments50/53€50k-
Cash at bank and in hand54/58€184k€239k▲
Deferred charges and accrued income490/1€1k-
Equity and liabilities
Total equity and liabilities10/49€341k€300k▼
Equity10/15€246k€246k=
Contributions10/11€5k€5k=
Reserves13€241k€241k=
Distributable reserves133€241k€241k=
Amounts payable17/49€95k€54k▼
Amounts payable within one year42/48€95k€54k▼
Trade debts44€1k€17▼
Suppliers440/4€1k€17▼
Taxes, remuneration and social security45€94k€3k▼
Taxes450/3€94k€3k▼
Remuneration and social security454/9€160-
Other amounts payable47/48-€51k
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€13k€1k▼
Other operating charges640/8€1k€1k▼
Non-recurring operating charges66A-€6k
Gross operating margin9900€147k€77k▼
Operating profit (loss)9901€133k€68k▼
Financial income75/76B€3k€2k▼
Recurring financial income75€3k€2k▼
Financial charges65/66B€250€291▲
Recurring financial charges65€250€291▲
Profit (loss) for the period before taxes9903€136k€70k▼
Income taxes67/77€41k€19k▼
Profit (loss) for the period9904€95k€51k▼
Profit (loss) for the period to be appropriated9905€95k€51k▼
Appropriation of the result
Profit (loss) to be appropriated9906€95k€51k▼
Transfer to equity691/2€95k-
To other reserves6921€95k-
Profit to be distributed694/7-€51k
Return on contributions (dividend)694-€51k
The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
27-03
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Weakest financial yearnet €51k ▼46.3%
Net result drops to €51k, the lowest in the series.
31-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2022net €95k ▲6%
Net result €95k, the highest in the series.
31-12
Financial
Equity above €200kEq €246k ▲63.3%
3 profitable years in a row build equity to €246k.
30-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Equity above €150kEq €151k ▲148%
2 profitable years in a row build equity to €151k.
26-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Charleroi · 1 establishment unit since 2022
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue de Wayaux 116041 CharleroiGround area
1,367 m²
Building footprint
194 m²
Volume, LiDAR
1,038 m³
Parcel 52028B0366/00K003, Wallonia · tallest building 7.5 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
QP4PHARMA
since 20222.328.055.626
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 52028B0366/00K003 | Wallonia | 1,367 m² | 1 · 194 m² | 7.5 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
EUGENIA MUSCOLO ASSOCIATI
BE 1003.776.388
Elsene · Eq €246,011
BK CONSULTING
BE 1006.366.387
Deinze · Eq €246,004
SPATIUM
BE 0872.767.495
Kortrijk · Eq €246,055
WOODPEACOCK
BE 0835.130.111
Etterbeek · Eq €246,058
AGUIDE-TRAINING
BE 0770.587.695
La Louvière · Eq €245,972
Of 82,562 companies in sector 70200 we hold annual accounts for 52,574. 38,987 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded21-02-2022
Fiscal year end31-12
Abbreviation FR
QP4PHARMA
Trade name FR
QP4PHARMA
Activities, NACEBEL 2025
70200Business and other management consultancy
47730Retail sale of pharmaceutical products
74999Other professional, scientific and technical activities
82990Other business support services
Sources
Crossroads Bank for EnterprisesNational Bank · 4 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.
Contact details
1 entryE-mail:cedric.wolf@hotmail.com